Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
about
Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER)Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donorsA functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinityThe Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung CancerStructural basis for substrate specificity in human monomeric carbonyl reductasesDetecting clusters of mutationsLong-term consequences of hematopoietic stem cell transplantation: current state of the science.Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.Interindividual variability in the cardiac expression of anthracycline reductases in donors with and without Down syndrome.MicroRNAs differentially regulate carbonyl reductase 1 (CBR1) gene expression dependent on the allele status of the common polymorphic variant rs9024.Doxorubicin pathways: pharmacodynamics and adverse effects.Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.The role of genetic variability in drug metabolism pathways in breast cancer prognosis.Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily.Development of a CART Model to Predict the Synthesis of Cardiotoxic Daunorubicinol in Heart Tissue Samples From Donors With and Without Down Syndrome.Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role?Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine.Effects of Sublethal Exposure to a Glyphosate-Based Herbicide Formulation on Metabolic Activities of Different Xenobiotic-Metabolizing Enzymes in Rats.Bioactivation of loxoprofen to a pharmacologically active metabolite and its disposition kinetics in human skin.
P2860
Q24336929-6C3E4E5A-EC12-4B9B-83C4-E2EEF34D59DAQ24646186-BCAF3E5B-8183-4AA8-8A93-636D7E3F361CQ24647984-ACFEDE30-CCFB-4802-A95B-33E8156FA996Q28395836-38EFB4D2-5AC5-49CF-BEF7-067302E89069Q28476175-DBBCE822-2B7B-4305-AEB6-6A5367C8C173Q30373381-53AE4449-0395-4C2E-88C5-B96DE07B8EB1Q33705877-97FBE290-B901-4D04-9DCC-AAA72A368635Q33747406-FD9AA06D-92C4-497B-8936-C440279AF1E7Q33784640-874C2161-37FE-4E94-B888-C24DFFF45BFDQ34469794-F669BB5A-BCF5-47BC-A37C-C34C5EDF077FQ35048393-B045AD5E-E049-4524-8519-DD4647AF5D26Q36058273-104E1055-FF64-4C1A-B2BA-9E75502EF405Q36497088-3ADF5C85-EDFB-4DEC-AD94-4A39326FFA19Q36761677-EF5F3E2B-BC14-4F23-993A-1167B242C7D5Q36948463-7CA62C4D-FF9D-45D8-804E-33C7F48E2EDCQ37351248-98696293-87A5-42FC-AFB6-C92049BCEAE7Q37390119-A4BE66F6-C036-4564-B540-C9B2B315A93DQ38933314-F8CAFFBB-D149-4F41-BFFC-5842425ED84DQ42130469-659E51C3-2F28-4DEB-813F-E43B2A387289Q46871860-22EF62A2-DD15-492C-8AC4-BF21C8E6A446Q50949191-063C7B89-5EBC-4038-8719-B32576BF399B
P2860
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@ast
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@en
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@nl
type
label
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@ast
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@en
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@nl
prefLabel
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@ast
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@en
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@nl
P356
P1476
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
@en
P2093
Javier G Blanco
Sukhwinder S Lakhman
P356
10.1124/DMD.104.002006
P407
P577
2005-02-01T00:00:00Z